×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Walking the Talk: What Happens When Clinical Trialists Join Clinical Trials?
Session Chair(s)
Jane Elizabeth Myles, MSc
Program Director
Decentralized Trials and Research Alliance, United States
In this forum we share experiences as volunteers in Phase 3 COVID-19 vaccine trials. Few of us enroll in trials, even though our work is designing, executing, and analyzing clinical trials. This is a way to learn through our participation.
Learning Objective : Discuss stories of participating in a COVID-19 vaccine trial as a healthy volunteer; Evaluate insights on the patient experience in the trial, and the key takeaways as a clinical trialist that are made clear by participation; Identify potential options for a different patient experience in future trials that leverage technology and other patient-centric trial solutions.
Speaker(s)
Panelist
Kelly Johnston McKee, MS
Medidata, United States
Vice President, Decentralized Clinical Trials
Panelist
Angela Radcliffe
Bristol-Myers Squibb Company , United States
Head, Data Governance and Stewardship
Panelist
Craig Serra, MBA, MS
Flatiron Health, United States
Head of Commercial Solutions and Partnerships
Have an account?